239 related articles for article (PubMed ID: 31197760)
1. Effects of malignancies on fertility preservation outcomes and relevant cryobiological advances.
Liu D; Yan J; Qiao J
Sci China Life Sci; 2020 Feb; 63(2):217-227. PubMed ID: 31197760
[TBL] [Abstract][Full Text] [Related]
2. In vitro maturation of human immature oocytes for fertility preservation.
Chian RC; Uzelac PS; Nargund G
Fertil Steril; 2013 Apr; 99(5):1173-81. PubMed ID: 23433515
[TBL] [Abstract][Full Text] [Related]
3. Random Start Ovarian Stimulation for Oocyte or Embryo Cryopreservation in Women Desiring Fertility Preservation Prior to Gonadotoxic Cancer Therapy.
Danis RB; Pereira N; Elias RT
Curr Pharm Biotechnol; 2017 Nov; 18(8):609-613. PubMed ID: 28786354
[TBL] [Abstract][Full Text] [Related]
4. Fertility preservation options in breast cancer patients.
Kasum M; von Wolff M; Franulić D; Čehić E; Klepac-Pulanić T; Orešković S; Juras J
Gynecol Endocrinol; 2015; 31(11):846-51. PubMed ID: 26370157
[TBL] [Abstract][Full Text] [Related]
5. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
[TBL] [Abstract][Full Text] [Related]
6. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response.
Alvarez RM; Ramanathan P
Hum Reprod; 2018 Nov; 33(11):2051-2059. PubMed ID: 27370358
[TBL] [Abstract][Full Text] [Related]
7. Fertility preservation in breast cancer patients.
El Hachem H; Atallah D; Grynberg M
Future Oncol; 2014 Aug; 10(10):1767-77. PubMed ID: 25303056
[TBL] [Abstract][Full Text] [Related]
8. Fertility preservation and reproductive health in the pediatric, adolescent, and young adult female cancer patient.
Trudgen K; Ayensu-Coker L
Curr Opin Obstet Gynecol; 2014 Oct; 26(5):372-80. PubMed ID: 25160517
[TBL] [Abstract][Full Text] [Related]
9. FERTILITY PRESERVATION IN YOUNG WOMEN WITH EARLY-STAGE BREAST CANCER.
Vuković P; Kasum M; Raguž J; Lonjak N; Bilić Knežević S; Orešković I; Beketić Orešković L; Čehić E
Acta Clin Croat; 2019 Mar; 58(1):147-156. PubMed ID: 31363337
[TBL] [Abstract][Full Text] [Related]
10. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation.
Gunnala V; Fields J; Irani M; D'Angelo D; Xu K; Schattman G; Rosenwaks Z
Fertil Steril; 2019 Feb; 111(2):363-371. PubMed ID: 30527950
[TBL] [Abstract][Full Text] [Related]
11. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
12. Response to ovarian stimulation is not impacted by a breast cancer diagnosis.
Quinn MM; Cakmak H; Letourneau JM; Cedars MI; Rosen MP
Hum Reprod; 2017 Mar; 32(3):568-574. PubMed ID: 28122888
[TBL] [Abstract][Full Text] [Related]
13. [Oncofertility and breast cancer].
Sonigo C; Grynberg M; Bringer S; Sermondade N
Bull Cancer; 2019 Dec; 106(12S1):S43-S52. PubMed ID: 32008738
[TBL] [Abstract][Full Text] [Related]
14. New trends in female fertility preservation: in vitro maturation of oocytes.
Berwanger AL; Finet A; El Hachem H; le Parco S; Hesters L; Grynberg M
Future Oncol; 2012 Dec; 8(12):1567-73. PubMed ID: 23231518
[TBL] [Abstract][Full Text] [Related]
15. Ovarian response and follow-up outcomes in women diagnosed with cancer having fertility preservation: Comparison of random start and early follicular phase stimulation - cohort study.
Muteshi C; Child T; Ohuma E; Fatum M
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():10-14. PubMed ID: 30227359
[TBL] [Abstract][Full Text] [Related]
16. Ovarian reserve and response to stimulation in women undergoing fertility preservation according to malignancy type.
Lefebvre T; Mirallié S; Leperlier F; Reignier A; Barrière P; Fréour T
Reprod Biomed Online; 2018 Aug; 37(2):201-207. PubMed ID: 29784618
[TBL] [Abstract][Full Text] [Related]
17. Hematological Malignancies and Fertility.
Ozdemir ZN; Bozdag SC
Adv Exp Med Biol; 2020; 1288():103-115. PubMed ID: 32124411
[TBL] [Abstract][Full Text] [Related]
18. What threshold values of antral follicle count and serum AMH levels should be considered for oocyte cryopreservation after in vitro maturation?
Sonigo C; Simon C; Boubaya M; Benoit A; Sifer C; Sermondade N; Grynberg M
Hum Reprod; 2016 Jul; 31(7):1493-500. PubMed ID: 27165625
[TBL] [Abstract][Full Text] [Related]
19. IVF for fertility preservation in breast cancer patients--efficacy and safety issues.
Shapira M; Raanani H; Meirow D
J Assist Reprod Genet; 2015 Aug; 32(8):1171-8. PubMed ID: 26126877
[TBL] [Abstract][Full Text] [Related]
20. Fertility after breast cancer treatment.
Kasum M; Beketić-Orešković L; Peddi PF; Orešković S; Johnson RH
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():13-8. PubMed ID: 24315568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
